(PharmaNewsWire.Com, January 26, 2018 ) The Global Bone Growth Stimulator Market accounted to USD 1.01 billion in 2016 growing at a CAGR of 5.7% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic year 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
Also the Global Bone Growth Stimulator Market By Product (Device, Boner Morphogenetic Protein, PRP), Application (Spinal Fusion, Delay Union & Non-union Bone Fracture, Oral-maxillofacial), End User (Hospitals, Home Care, Academia, CROs), Geography (North America, Europe, Asia-Pacific, Europe, South America, Middle East and Africa) – Industry Trends and Forecast to 2024.
Bone growth stimulator is a type of therapy which is utilized as a part of instances of delay or failure of fracture healing as they upgrade the bone-healing process without the vibe of electrical currents or vibrations when worn by the client in faster way. Bone development stimulators gadgets work by discharging either a low-level pulsed ultrasonic vitality or beat electromagnetic field as it helps in repairing the damaged tissues and cell formation.
Increasing number of patients related to bone related problems
Market Segmentation: Global Bone Growth Stimulator Market
On the basis of product, global bone growth stimulator market is segmented into device, boner morphogenetic protein and Platelet Rich Plasma (PRP). In 2016, the devices segment accounted the largest market share due to increase in rising population and non-surgical treatment methods.
On the basis of application, global bone growth stimulator market is segmented into spinal fusion, delay union & non-union bone fracture, and oral-maxillofacial. In 2016, spinal fusion segment has accounted the largest market share due to the continuous use of bone growth stimulator products and rise in aging population.
On the basis of end user, global bone growth stimulator market is segmented into hospitals, homecare, academia and CROs. Hospital segment is expected to witness the highest CAGR in the forecast period 2017-2024.
Competitive Analysis: Global Bone Growth Stimulator Market
The global bone growth stimulator market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes bone growth stimulator market shares for global, Europe, North America, Asia Pacific, and South America.
Major Market Competitors: Global Bone Growth Stimulator Market
Some of the major players of the bone growth stimulator market are Orthofix Holdings, Inc, Bioventus, DJO Finance LLC, Medtronic, Zimmer Biomet, Ossatec Benelux BV, IGEA S.p.A., Stryker, Arthrex, Inc., DePuySynthes Companies, elizur corporation, Isto Biologics, Ember Therapeutics, Altis Biologics, Regen Lab, SA., Verve Consulting, Smith & Nephew Plc., Harvest Technologies Corporation and Aetna, Inc. among others.
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
